Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03530072 · ClinicalTrials.gov registry record
Use of NGS Cell-free Pathogen Test for Identification of Low Risk Fever & Neutropenia in Pediatric Patients
A clinical trial, sponsored by Karius.
- Completed
- Registry status
- 15
- Enrollment target
NCT03530072 is a clinical trial that has completed, run by Karius. The registered enrollment target is 15 participants.
The verdict
NCT03530072 has completed, sponsored by Karius.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
Febrile neutropenia is a common complication in pediatric oncology patients. Standard of care requires admission of all patients for intravenous antibiotics until cultures are negative, patients are afebrile and there are signs of bone marrow recovery. This often results in prolonged hospital admissions with significant financial costs, decreased quality of life and potential secondary infections. More recent data suggests it may be possible to identify a "low risk" group that can be discharged prior to signs of bone marrow recovery. At this time, researchers have been unable to identify a model that is safe for early discharge across institutions.
Interventions
- DIAGNOSTIC_TEST Karius Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-05-07 |
| Est. Completion | 2019-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03530072
The ClinicalTrials.gov registry entry for NCT03530072 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Karius, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Karius Test is the first listed.
NCT03530072 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03530072 about?
NCT03530072 is a clinical study titled "Use of NGS Cell-free Pathogen Test for Identification of Low Risk Fever & Neutropenia in Pediatric Patients". Febrile neutropenia is a common complication in pediatric oncology patients. Standard of care requires admission of all patients for intravenous antibiotics until cultures are negative, patients are afebrile and there are signs of bone marrow recovery. This often results in prolonged hospital admiss...
What is the current status of trial NCT03530072?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2018-05-07. Estimated completion is 2019-10-31.
What interventions are being tested in trial NCT03530072?
The interventions under investigation include: Karius Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03530072?
This trial is sponsored by Karius, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.